The Role of miR-128 in Neurodegenerative Diseases
International Journal of Molecular Sciences · 23.03.2023 · 24 (7) · 6024
DOI: 10.3390/ijms24076024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2023. Verfasst von Marika Lanza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 31-98166 M…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Huntington Disease, Alzheimer Disease, Parkinson Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several neurodegenerative disorders are characterized by the accumulation of misfolded proteins and are collectively known as proteinopathies. Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) represent some of the most common neurodegenerative disorders whose steady increase in prevalence is having a major socio-economic impact on our society. Multiple laboratories have reported hundreds of changes in gene expression in selective brain regions of AD, PD, and HD brains. While the mechanisms underlying these changes remain an active area of investigation, alterations in the expression of noncoding RNAs, which are common in AD, PD, and HD, may account for some of the changes in gene expression in proteinopathies. In this review, we discuss the role of miR-128, which is highly expressed in mammalian brains, in AD, PD, and HD. We highlight how alterations in miR-128 may account, at least in part, for the gene expression changes associated with proteinopathies. Indeed, miR-128 is involved, among other things, in the regulation of neuronal plasticity, cytoskeletal organization, and neuronal death, events linked to various proteinopathies. For example, reducing the expression of miR-128 in a mouse model of AD ameliorates cognitive deficits and reduces neuropathology. Overall, the data in the literature suggest that targeting miR-128 might be beneficial to mitigate the behavioral phenotype associated with these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 31-98166 Messina, Italy.
ORCID-Profile: Salvatore Cuzzocrea, Salvatore Oddo, Emanuela Esposito
Zitieren
APA
Lanza, M., Cuzzocrea, S., Oddo, S., Esposito, E., & Casili, G. (2023). The Role of miR-128 in Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(7), 6024. https://doi.org/10.3390/ijms24076024
Vancouver
Lanza M, Cuzzocrea S, Oddo S, Esposito E, Casili G. The Role of miR-128 in Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;24(7):6024. doi:10.3390/ijms24076024
BibTeX
@article{Lanza2023,
author = {Lanza, Marika and Cuzzocrea, Salvatore and Oddo, Salvatore and Esposito, Emanuela and Casili, Giovanna},
title = {The Role of miR-128 in Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6024},
doi = {10.3390/ijms24076024}
}
EUVIMED